-
Highlights of the Safety Committee: January 2023
Highlights of the Safety Committee: January 2023
-
Highlights of the Safety Committee: January 2023
Highlights of the Safety Committee: January 2023
PRAC recommends aligning the dosing of Janus kinase (JAK) inhibitors in patients with certain risk factors
-
Implementation of the Clinical Trials Regulation
Implementation of the Clinical Trials Regulation
-
Implementation of the Clinical Trials Regulation
Implementation of the Clinical Trials Regulation
On 31 January 2023, the Clinical Trials Information System (CTIS) will become mandatory for all authorisation applications for a clinical trial in the EU
-
End-of-year message from EMA’s Executive Director
End-of-year message from EMA’s Executive Director
-
End-of-year message from EMA’s Executive Director
End-of-year message from EMA’s Executive Director
In this statement, Executive Director Emer Cooke looks back at 2022 and gives insights into the year ahead
-
Facilitating EU Decentralised Clinical Trials
Facilitating EU Decentralised Clinical Trials
-
Facilitating EU Decentralised Clinical Trials
Facilitating EU Decentralised Clinical Trials
As part of ACT EU, EMA, the European Commission and the Heads of Medicines Agencies published recommendations to facilitate the conduct of decentralised clinical trials in the EU
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal